logo
After 33 years, Centre holds review meeting; long working hours for resident docs discussed

After 33 years, Centre holds review meeting; long working hours for resident docs discussed

NEW DELHI: After 33 years, the centre held a high-level meeting on Tuesday to review and update the Central Residency Scheme, 1992.
The meeting, chaired by the newly appointed Additional Director General of Health Services (DGHS), Dr Sunita Sharma, discussed issues such as hostel facilities, long working hours, and salaries of resident doctors - both junior and senior resident doctors - who form the backbone of government hospitals.
'We held the first meeting today and discussed various issues. We will meet again,' Dr Atul Goel, Director General of Health Services (DGHS), told this paper.
He said no final decision was made on the issues that were taken up and that the ministry would give its final approval.
However, various resident doctor associations claimed that their top demand of a fixed 48-hour per week working hours for resident doctors had been accepted.
In the meeting, attended by directors of all major Delhi-based government hospitals, members of the Indian Medical Association (IMA), and various representatives of all major resident doctors' associations, including FAIMA, FORDA, UDF, and IMA-JDN, various issues like hostel facilities, thesis grants, assistant professor salaries, and health benefits for postgraduate and senior resident doctors were discussed.
Welcoming the move to hold the first meeting in three decades, Dr Rohan Krishnan, the Federation of All India Medical Association (FAIMA) 's chief patron, said all their points were taken up.
'One of the crucial issues was the long working hours of senior and junior resident doctors. We had proposed that it should not exceed 48 hours a week with at least one off every week on a rotation basis. The ministry accepted this,' he said.
'The central residency scheme has not been revised since 1992. We feel resident doctors will be more comfortable in the safe working environment, leading to better patient care. If the basic needs of the resident doctors are met, then I think there would be better care for the patients,' he told this paper.
He said FAIMA had made the demand with the central government to review the Central Residency Scheme during the RG Kar incident in which a postgraduate doctor was brutally raped and murdered in a government hospital in Kolkata last year.
Dr Lakshya Mittal, National President of United Doctors' Front (UDF) on X, said it was a big win for resident doctors. "After today's DGHS meeting, it is confirmed 48 hours/week fixed duty hours will replace the vague term 'reasonable.' He also said the allowance revision was approved.
Dr Dhruv Chauhan, National Spokesperson, Indian Medical Association (IMA)-Junior Doctors Network (IMA-JDN), said, 'It was a fruitful meeting, and they have taken note of all the concerns we raised, including ensuring 48 hours/week fixed duty hours for all resident doctors."
"Allowances revision for doctors and fixed amount for thesis and books also approved in the meeting and taken further for implementation,' he told this paper.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Nitazene: All About Drug That's Upto 500 Times Stronger Than Heroin
Nitazene: All About Drug That's Upto 500 Times Stronger Than Heroin

NDTV

time2 hours ago

  • NDTV

Nitazene: All About Drug That's Upto 500 Times Stronger Than Heroin

A drug, believed to be 50-500 times more effective than heroin, has become a major cause of concern in London, UK. Authorities have issued a warning over the deadly synthetic opioid named Nitazene, which is gaining popularity among partygoers. The drug, which is apparently similar to fentanyl, is suspected to be the reason behind two recent deaths, the BBC reported, adding that even tiny doses can be fatal. The Metropolitan Police said that an investigation is underway into the "sudden deaths" of a 28-year-old man and a 20-year-old woman in Southall on May 26. "This is following reports that the individuals allegedly passed away after taking an illicit substance in the form of a green pill," a spokesperson for the force said as quoted by the BBC. The Loop, a UK-based drug testing charity, said that the pills contain synthetic opioids called Nitazenes. The pills can be "50 to 500 times stronger than heroin", and they look like oxycodone pills (oxys). In an Instagram post, East London nightclub The Cause said that the pills had caused "several hospitalisations across multiple London venues". What are nitazenes? Nitazenes were developed in the 1950s as pain-relieving agents. BBC reported that these drugs suppress the respiratory system, hence, people die as they stop breathing. The report also noted that a person can be saved by taking naloxone, which is an antidote. There have been at least 18 deaths linked to nitazenes in London from May 2023 to June 2024, as per the most recent government data. The European Union Drugs Agency (EUDA) in a recent report highlighted rapid shifts in Europe's drug market. The report noted that this trend has created new health and security risks. As per EUDA, a total of 88 new synthetic opioids have appeared on the European market since 2009. All of the seven new synthetic opioids formally notified to the EWS were nitazenes in 2024. A total of 22 nitazenes are being monitored in Europe to date in Europe. "A recent EUDA pilot threat assessment, focusing on new synthetic opioids in the Baltics, found that nitazenes accounted for a significant share of overdose deaths in Estonia and Latvia. In 2024, at least seven EU Member States and Norway reported harms linked to nitazenes," the EUDA report read.

Covid-19 India Update: Gujarat Reports 158 New Cases, Country's Active Infection Count Near 6,500
Covid-19 India Update: Gujarat Reports 158 New Cases, Country's Active Infection Count Near 6,500

News18

time4 hours ago

  • News18

Covid-19 India Update: Gujarat Reports 158 New Cases, Country's Active Infection Count Near 6,500

Last Updated: India reported 358 new Covid-19 cases, with Gujarat recording the highest at 158. Kerala has the highest overall active cases at 1,957. India reported 358 Covid-19 cases in the last 24 hours, taking the country's total active infections to 6,491. With 158 cases, Gujarat recorded the highest number of fresh infections among all states and union territories, followed by Karnataka (57), West Bengal (54), Delhi (42), and Tamil Nadu (25). According to data released by the Union Health Ministry on Monday, Kerala has reported the highest overall number of Covid-19 cases (1,957), followed by Gujarat (980), West Bengal (747), Delhi (728), Maharashtra (607), and Karnataka (423). Most Covid Cases Mild Due to the rising Covid-19 cases, the Centre is conducting mock drills to check facility-level preparedness and has instructed all states to ensure availability of oxygen, isolation beds, ventilators, and essential medicines, official sources had said. Official sources have maintained that most cases are mild and managed under home care. A series of technical review meetings were held on June 2 and 3 under the chairpersonship of Dr Sunita Sharma, Director General of Health Services, to evaluate the Covid situation and preparedness measures. Representatives from the Disaster Management Cell, Emergency Management Response Cell, National Centre for Disease Control, Indian Council of Medical Research, Integrated Disease Surveillance Programme, central government hospitals in Delhi, and all states and Union Territories were part of the meeting. 'Testing is recommended for all admitted SARI cases and 5 per cent of ILI cases as per guidelines, and positive SARI samples are sent for Whole Genome Sequencing through the ICMR VRDL network, " an official source said. Covid-19 Surge As of June 2025, Covid-19 continues to pose a global health challenge, with a noticeable uptick in cases reported across several regions. According to the World Health Organization, over 150,000 new Covid-19 cases were recorded in 90 countries between April 21 and May 18, 2025—an increase compared to the previous 28-day period. Test positivity rates have climbed to 11 per cent in 73 countries, reaching levels last seen in July 2024. The surge is most pronounced in the Eastern Mediterranean, Southeast Asia, and Western Pacific regions, largely driven by emerging variants such as NB.1.8.1. (With PTI inputs) First Published: June 09, 2025, 14:25 IST

L'Oreal buys British skincare brand Medik8
L'Oreal buys British skincare brand Medik8

Time of India

time5 hours ago

  • Time of India

L'Oreal buys British skincare brand Medik8

L'Oreal is to acquire British skincare brand Medik8 , its owner, Britain-based private equity firm Inflexion, said on Monday, boosting the French cosmetics giant's offering in the fast-growing dermatological skincare market . The size of the deal was not disclosed. Medik8 focuses on vitamin A-based anti-ageing creams and serums. "The partnership with L'Oreal will allow Medik8 to deepen its presence in existing markets and expand globally. As part of the transaction, Inflexion will retain a minority shareholding in Medik8," the private equity firm said in a statement. L'Oreal's dermatological beauty division, which includes major brands like CeraVe, La Roche-Posay, and SkinCeuticals, has been its fastest growing in recent years, reaching revenues of 7 billion euros (USD 7.99 billion) last year, after growing almost 10% on the year before. The business, which also has the highest profit margin among its four divisions, has boomed on growing consumer interest in science-backed products, though growth has slowed recently due to rising competition. L'Oreal executives said this year they were pursuing acquisitions and looking to revive flagging growth. The company acquired Korean skincare brand, Dr.G, in December and also bought a minority stake in Oman-based perfume house Amourage last year.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store